CITADEL ADVISORS LLC 13D and 13G filings for PMV Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:58 pm Sale | 2023-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP | CITADEL ADVISORS LLC | 1,236,850 2.400% | -1,022,891 (-45.27%) | Filing |
| 2023-05-19 4:05 pm Purchase | 2023-05-09 | 13G | PMV Pharmaceuticals, Inc. PMVP | CITADEL ADVISORS LLC | 2,259,741 4.900% | 875,242 (+63.22%) | Filing |
| 2023-02-14 08:26 am Sale | 2022-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP | CITADEL ADVISORS LLC | 1,384,499 3.000% | -1,025,343 (-42.55%) | Filing |
| 2022-06-17 4:02 pm Purchase | 2022-06-07 | 13G | PMV Pharmaceuticals, Inc. PMVP | CITADEL ADVISORS LLC | 2,409,842 5.300% | 2,409,842 (New Position) | Filing |